Product
ACP-204
2 clinical trials
1 indication
Indication
Alzheimer's Disease PsychosisClinical trial
A 52-Week, Open-Label Extension Study of ACP-204 in Adults With Alzheimer's Disease PsychosisStatus: Not yet recruiting, Estimated PCD: 2029-04-01
Clinical trial
A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease PsychosisStatus: Recruiting, Estimated PCD: 2028-01-01